Evidence map›Paper›PMID 29905905›Full record

ArticleAmino acids2018

Selective modification of fluciclovine (

F I Tade, W G Wiles, G Lu, B Bilir, O Akin-Akintayo, J S Lee, D Patil, W Yu, C Ormenisan Gherasim, B Fei and 7 more

Open access · greenAbstract read
In one paragraph

Article in Amino acids, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

F I TadeDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.
W G WilesWinship Cancer Institute, Atlanta, GA, USA.
G LuDepartment of Otolaryngology, Stanford University, Stanford, CA, USA.
B BilirDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
O Akin-AkintayoDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.
J S LeeDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.
D PatilWinship Cancer Institute, Atlanta, GA, USA.
W YuDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.
C Ormenisan GherasimDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
B FeiDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.
C S MorenoDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
A O OsunkoyaWinship Cancer Institute, Atlanta, GA, USA.
E J TeohDepartment of Oncology, Cancer Imaging Centre Oxford, University of Oxford, Oxford, UK.
S OkaResearch Center, Nihon Medi-Physics Co., Ltd., Chiba, 299-0266, Japan.
H OkudairaResearch Center, Nihon Medi-Physics Co., Ltd., Chiba, 299-0266, Japan.
M M GoodmanDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.
D M SchusterDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA. dschust@emory.edu.
Emory University · USNihon Medi-Physics (Japan) · JPPiedmont Cancer Institute · USCancer Research UK Oxford Centre · GBStanford University · US

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
Image-guided Intravascular Robotic System for Mitral Valve Repair and ImplantsR01HL140325 · NHLBI · GEORGIA INSTITUTE OF TECHNOLOGY · PI DESAI, JAYDEV P., FEI, BAOWEI · 2018 to 2021
$3.0M
ACADEMIC-INDUSTRIAL PARTNERSHIP FOR TRANSLATION OF PET/TRUS GUIDED INTERVENTIONR01CA204254 · NCI · UNIVERSITY OF TEXAS DALLAS · PI FEI, BAOWEI · 2017 to 2021
$2.0M
MOLECULAR IMAGING DIRECTED, 3D ULTRASOUND-GUIDED, BIOPSY SYSTEMR01CA156775 · NCI · UNIVERSITY OF TEXAS DALLAS · PI FEI, BAOWEI · 2011 to 2016
$1.7M
STAN-CT: Standardization and Normalization of CT images for Lung Cancer PatientsR21CA231911 · NCI · UNIVERSITY OF KENTUCKY · PI CHEN, JIN, FEI, BAOWEI · 2019 to 2020
$389k
NCI NIH HHS P30 CA138292NCI NIH HHS R01 CA156775NCI NIH HHS R01 CA204254NCI NIH HHS R21 CA231911NHLBI NIH HHS R01 HL140325
6 · The paper itself

Abstract

We investigated if previously demonstrated inhibition of fluciclovine (

Indexed as

AnimalsBiological TransportCarboxylic AcidsCell Line, TumorCyclobutanesHeterograftsHumansLuminescenceMaleMiceMice, NudePositron Emission Tomography Computed TomographyProstateProstatic NeoplasmsCarboxylic AcidsCyclobutanesfluciclovine F-18Amino acid transportAxuminFluciclovinePC3Prostate cancer

Identifiers

PMID29905905
PMCPMC7261602
OpenAlexW2808496632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.